Verified profile

Judith A. Waltz

Healthcare, Gov. Investigations, False Claims Acts, CIAs

Judith A. Waltz's profile photo
LocationSan FranciscoCalifornia, United States
Current rolePartner, Chair of Health Care Practice GroupFoley & Lardner LLP · since Jul 1998
Government service15yrsOffice for Civil Rights, Department of Health and Human Services · Court of Appeals

About

Judith (Judy) A. Waltz is a health care partner with Foley & Lardner LLP. Her practice focuses on government investigations, false claims acts, corporate integrity agreements (CIAs), reimbursement strategies, bankruptcy, Medicare and Medicaid compliance counseling, and Medicare/Medicaid overpayments and enrollment disputes. Judith works with clients in various areas of the health care industry. She is the chair of the firm’s Health Care Practice Group and co-chair of the Health Care & Life Sciences Sector’s Providers of Health Care Services Area of Focus. Judith is also a member of the Government Enforcement Defense & Investigations and Bankruptcy & Business Reorganizations Practices.

Fraud and Abuse, FCA and Health Care Fraud Investigations

Judith regularly advises clients who are the focus of government investigations and other enforcement actions and has negotiated false claims act settlements with the U.S. Department of Justice as well as corporate integrity agreements (CIAs) with the Office of Inspector General. She then has worked closely with those clients to implement their CIAs, including ongoing advice in connection with IRO audits and reviews. At the state level, she has been involved with various Medi-Cal audits, payment suspensions, and investigations, including a matter involving allegations of inflated drug pricing by a major pharmaceutical company.

Medicare and Medicaid

Judith also provides ongoing compliance counseling and Medicare and Medicaid payment advice to clients, which include hospices, large physician practices, county health systems, hospitals, durable medical equipment suppliers, clinical laboratories, dialysis companies, skilled nursing facilities, ambulance companies, pharmacies, managed care providers, and a variety of other health care entities. In 2013, she served as special Medicare counsel in the bankruptcy of San Diego Hospice, a large not-for-profit entity. Judith has advised clients (including physician practices, hospices, and hospitals) undergoing UPIC, ZPIC, RAC audits, other Medicare or Medicaid audits, overpayments, and pre-pay reviews. She is experienced in Medicare and Medi-Cal provider enrollment appeals and Medicare billing number revocations and other enforcement actions.

Prior to joining the firm in 1998, Judith served as assistant regional counsel for the U.S. Department of Health and Human Services in San Francisco, primarily handling Medicare issues including survey and certification and various types of reimbursement disputes. In that position, she appeared frequently before the Ninth Circuit and other federal courts in matters primarily involving payment disputes (including PRRB appeals), bankruptcy issues, and Medicare Secondary Payer (MSP) disputes. She held collateral appointments as a special assistant United States attorney for the Eastern and Northern districts of California.

Health Care Litigation

As assistant regional counsel for the Department of Health and Human Services for 12 years, Judith represented the secretary in the Ninth Circuit and other federal courts in matters primarily relating to disputes regarding Medicare payments to providers and suppliers. These cases included several court appeals of Provider Reimbursement Review Board decisions involving Medicare cost reports. In the bankruptcy and district courts, she represented the Department of Health and Health and Human Services in a precedential case, In re TLC Hospitals, Inc., later decided by the 9th Circuit in 224 F.3d 1008 (9th Cir. 2000), upholding Medicare’s ability to recoup pre-petition overpayments from post-petition overpayments. She also represented the government in various bankruptcy court actions involving the assumption of the Medicare provider agreement as an executory contract, a debtor’s challenge to a hospital decertification action taken post-petition, and post-petition payment suspension actions. As an additional part of her government representation, she served as primary counsel in various proceedings involving the Medicare Secondary Payer (MSP) provisions. Judith has represented providers and suppliers who are under investigation relating to their participation in the Medicare and Medi-Cal programs, including negotiating settlements and corporate integrity agreements relating to issues including hospice admissions, clinical laboratory claims, partial hospitalization services, inpatient short stays, costs claimed on cost reports, oxygen (DME) billing, and assorted allegations of upcoding. She also served as lead counsel in an administrative appeal of the imposition of a Medi-Cal civil money penalty. She has appeared in several administrative appeals before the federal HHS Departmental Appeals Board, including decertification actions taken under the Clinical Laboratory Improvement Act (CLIA), civil monetary penalties and adverse enrollment actions, and in overpayment appeals heard by the Office of Medicare Hearings and Appeals. In addition, she has represented providers and suppliers in the OIG’s Self-Disclosure Protocol, and in CMS’s Self-Disclosure Referral Protocol.

Telemedicine Experience

Judith has advised on compliance and reimbursement issues relating to business structures for providing telemedicine, requirements of the Medicare Conditions of Participation for hospitals that are participating in telemedicine services, applicable Medicare and Medicaid enrollment issues for telemedicine providers, and operational issues such as supervision of non-physician practitioners across sites. She has also worked extensively with the Clinical Laboratory Improvement Act (CLIA), payer, and compliance requirements regarding laboratory verbal and electronic orders and results.

Roles

Jul 1998–Present
Current role

Partner, Chair of Health Care Practice Group

Foley & Lardner LLP

San Francisco, California

Healthcare ServicesLegal AssistanceLegal Investigator

Chambers Band 1 for Health Care in California; Practice involves Medicare/Medicaid coverage, reimbursement, compliance and enforcement actions; negotiated settlements of False Claims Act cases and negotiated Corporate Integrity Agreements; administrative litigation including provider enrollment appeals, clinical laboratory improvement act (CLIA) enforcement

Jan 1986–Jan 1998
Former role

Assistant Regional Counsel

Office for Civil Rights, Department of Health and Human Services

(appointed)California

Reimbursement SpecialistHealthcare ServicesHealth LawTax AttorneyTax Law

Primarily handling Medicare cases, including reimbursement appeals (PRRB), Medicare Secondary Payer (MSP) matters, bankruptcy litigation, overpayments, survey/certification actions, EAJA

Oct 1982–Jul 1986
Former role

Staff Attorney

Court of Appeals

(appointed)California

Hearings and AppealsLegal AssistanceHealth Law

Publications & speeches

Medicare Overpayments: CMS Issues Final Regulations Implementing Changes to 60-day Refund Rule

Health Care Law Today

November 2024

Summary. The Final Rule’s overpayment provisions are a significant change to the existing regulations, which date back to 2016 for the Parts A/B rules and 2014 for the Parts C/D Rule. Most importantly, the Final Rule adopts that part of the 2022 Proposed Rule that drops the standard of “reasonable diligence” as to when a person has identified an overpayment. The Final Rule adopts a revised standard that tracks and cites to the Federal False Claims Act for a person that “knowingly receives or retains an overpayment.” This revised standard covers situations where the person (as defined) has actual knowledge of the existence of the overpayment or acts in reckless disregard of or deliberate ignorance of the overpayment. The statute itself does not define what it means to “identify” an overpayment, likely suggesting a future opportunity for a Loper Bright challenge to the new regulation.

Link

“Medicare Coverage: CMS Finalizes New Pathway for Breakthrough Devices”

Health Care Law Today

October 2024

Co-Author

Link

“Health Care Enforcement: ‘Tea Leaves’ in the 2024 National Health Care Fraud Summer Takedown”

Health Care Law Today

August 2024

Co-Author

Link

“What Does the End of Chevron Deference Mean for Federal Health Care Programs?”

Health Care Law Today

July 2024

Link

“Health Care Private Equity: Senate Budget Committee Investigates Hospital Ownership”

Health Care Law Today

December 2023

Link

“Administrative Enforcement: Collateral Consequences of Compliance Failures”

AHLA Institute on Medicare and Medicaid Payment Issues — Boltimore, MD

March 2025

Foley partner Judy Waltz, chair of Foley’s Health Care Practice Group, is speaking in the American Health Law Association Institute (AHLA) on Medicare and Medicaid Payment Issues in the session “Administrative Enforcement: Collateral Consequences of Compliance Failures” on March 27. The presentation will cover: Federal Administrative Law Post Loper Bright, Jarkesy and Corner Post, and Executive Orders Administrative Enforcement Authorities Denial/Revocation of Medicare/Medicaid Billing Privileges Cross-state Medicaid Actions (Collateral Terminations) and Preclusion List Office of Inspector General (OIG) Exclusions Civil Monetary Penalties Payment Suspensions Case Study: A Physician in Trouble The AHLA Institute on Medicare and Medicaid Payment Issues is an opportunity for deep exploration of the full range of risks and opportunities relating to participation in federal health care payment programs.

Link

“Key Takeaways: 7th Annual “Let’s Talk Compliance”

Health Care Law Today — Virtual Conference

March 2025

The Trump Administration has confirmed by recent actions and comments that identifying fraud, waste, and abuse (collectively referenced below as “fraud”) in the Medicare and Medicaid programs will continue to be a top enforcement priority. See e.g., NPR’s article “DOGE sets its sights on Medicare and Medicaid.” Early actions from the Department of Government Efficiency (DOGE) suggest an increased focus on datamining to identify suspected fraud.

Link

“Corporate Integrity Agreements: Independent Review of Organizations and the Office of the Inspector General”

HCCA Board & Compliance Committee Conference

February 2025

“New Compliance Directions for Medicare Managed Care Plans and the Impact for Providers”

HCCA San Francisco Regional Health Care Compliance Conference — San Francisco, CA

December 2024

“Chevron’s Demise and its Impact on Healthcare”

CSHA Fall Seminar

November 2024